Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis

Published:2024 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Soto Felipe,Glick Lydia,Chan Colin,Zhong Linda,Wilson Nathaniel,Faiz Saadia A.,Gandhi Saumil,Naing Aung,Heymach John,Shannon Vickie R.,Franco-Vega Maria,Liao Zhongxing,Lin Steven H.,Palaskas Nicolas,Wu Jia,Shroff Girish,Altan Mehmet,Sheshadri Ajay

Publisher

Elsevier BV

Reference28 articles.

1. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs;A Haslam;JAMA Network Open,2019

2. Cancer statistics;L R Siegel;Cancer Journal for Clinicians,2024

3. Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer;J S Antonia;New England Journal of Medicine,2017

4. Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study;L M Johnson;Journal of Clinical Oncology,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP